USA Knotless Surgical Sutures Market is Likely to Witness Steady Growth by 2033

According to Future Market Insights research, the Knotless Surgical Sutures Market in the United States is estimated to develop at a CAGR of 3.6% during the forecast period. The market value is expected to rise from 181.0 million US$ in 2023 to US$ 258.7 million by 2033. The USA Knotless Surgical Sutures market was valued at US$ 175.7 million at the end of 2022 and is expected to rise 3.1% year on year in 2023.

Over the years, the USA market for Knotless Surgical Sutures has seen tremendous growth. Key factors driving the market include technological advancements in terms of the usage of synthetic materials in creating surgical sutures, the development of absorbable sutures, increasing export opportunities, and rising disposable income.

Leading companies are inclined towards extensive research in order to develop new and improved versions of Knotless Surgical Sutures. These include sutures with synthetic materials to provide exceptional tissue holding properties, sutures with properties like antibacterial or Triclosan-coated polyglactin 910 coated sutures, barbed sutures, sutures with braiding technologies, or absorbable sutures made of fibresthat line animal intestines or artificially created polymers.

The rise in disposable income is expected to be another important factor driving the growth of the Knotless Surgical Sutures market. Increasing disposable income enables an excellent growth opportunity for surgical suture manufacturers to connect with potential end users.

Key Companies Profiled

  • Medtronic
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson (Ethicon)
  • CONMED Corporation
  • Corza Medical
  • CP Medical
  • DemeTECH Corporation
  • Sutumed
  • DSI Dental Solution
  • Golnit Sutures
  • Vital Sutures
  • Atramat

Read More Details@ https://www.futuremarketinsights.com/reports/usa-knotless-surgical-sutures-market

Key Segments Covered in Knotless Surgical Sutures Industry Research

By Product:

  • Absorbable Surgical Sutures
  • Non- Absorbable Surgical Sutures

By Raw Material:

  • Polyglycolic Acid Absorbable Surgical Suture
  • Polyglactin Absorbable Surgical Sutures
  • Catgut Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polyester Non-Absorbable Surgical Sutures
  • Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures

By Source:

  • Natural
  • Synthetic
    • Monofilament
    • Braided
  • Coated
  • Uncoated

By Application:

  • Cardiovascular Procedures
  • General Surgery Procedures
  • Ophthalmic Procedures
  • Orthopedic Procedures
  • Dental Procedures
  • Gastroenterology Procedures
  • Gynecology Procedures
  • Plastic Surgery Procedures
  • Veterinary Procedures

By End User:

  • Hospital Laboratories
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Veterinary Hospitals
  • Veterinary Clinics

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more